Evaluation of the efficacy of melarsenoxyde cysteamine (Cymelarsan) in treatment of camels experimentally infected with Trypanosoma evansi using antigen trapping enzyme-linked immunosorbent assay.
Nyang'ao
J M
JM
Kenya Trypanosomiasis Research Institute KETRI, Kikuyu.
Olaho-Mukani
W
W
Maribei
J M
JM
Omuse
J K
JK
D000818:Animals; D000913:Antibodies, Protozoan / Q000032:analysis; D000953:Antigens, Protozoan / Q000032:analysis; D001152:Arsenicals / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002162:Camelus / Q000469:parasitology*; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D051379:Mice; D014344:Trypanocidal Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D014345:Trypanosoma / Q000187:drug effects* / Q000276:immunology; D014352:Trypanosomiasis / Q000188:drug therapy / Q000662:veterinary*
D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D001152:Arsenicals; D014344:Trypanocidal Agents; C062789:melaminylthioarsenate